VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,097 | -39.7% | 63,217 | -8.0% | 0.00% | -100.0% |
| Q2 2023 | $453,010 | -5.2% | 68,742 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $477,697 | -9.3% | 70,353 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $526,678 | -24.4% | 71,269 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $697,000 | -11.3% | 70,520 | -2.2% | 0.00% | 0.0% |
| Q2 2022 | $786,000 | -1.6% | 72,127 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $799,000 | -33.5% | 70,609 | -7.8% | 0.00% | 0.0% |
| Q4 2021 | $1,201,000 | -6.5% | 76,548 | +2.1% | 0.00% | -50.0% |
| Q3 2021 | $1,285,000 | -21.0% | 74,958 | -0.9% | 0.00% | 0.0% |
| Q2 2021 | $1,627,000 | +33.7% | 75,641 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $1,217,000 | +14.0% | 81,037 | -0.3% | 0.00% | +100.0% |
| Q4 2020 | $1,068,000 | +36.1% | 81,250 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $785,000 | -14.0% | 81,250 | +1.8% | 0.00% | -50.0% |
| Q2 2020 | $913,000 | +12.9% | 79,832 | +2.2% | 0.00% | 0.0% |
| Q1 2020 | $809,000 | -37.6% | 78,121 | -1.2% | 0.00% | 0.0% |
| Q4 2019 | $1,297,000 | +20.3% | 79,058 | -2.6% | 0.00% | 0.0% |
| Q3 2019 | $1,078,000 | -4.6% | 81,144 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $1,130,000 | -22.4% | 80,175 | +1.2% | 0.00% | -33.3% |
| Q1 2019 | $1,457,000 | -30.7% | 79,195 | -1.5% | 0.00% | -40.0% |
| Q4 2018 | $2,102,000 | +16.6% | 80,425 | +2.4% | 0.01% | +25.0% |
| Q3 2018 | $1,803,000 | +20.4% | 78,556 | -0.0% | 0.00% | +33.3% |
| Q2 2018 | $1,497,000 | +32.7% | 78,585 | +17.4% | 0.00% | +50.0% |
| Q1 2018 | $1,128,000 | +6.2% | 66,935 | -4.2% | 0.00% | 0.0% |
| Q4 2017 | $1,062,000 | -16.0% | 69,881 | -1.1% | 0.00% | -33.3% |
| Q3 2017 | $1,265,000 | -0.6% | 70,681 | -9.4% | 0.00% | 0.0% |
| Q2 2017 | $1,272,000 | +25.9% | 78,040 | +8.2% | 0.00% | +50.0% |
| Q1 2017 | $1,010,000 | -16.2% | 72,140 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $1,205,000 | -6.7% | 75,540 | -2.7% | 0.00% | -33.3% |
| Q3 2016 | $1,292,000 | +50.2% | 77,640 | +1.0% | 0.00% | +50.0% |
| Q2 2016 | $860,000 | +16.1% | 76,840 | -13.3% | 0.00% | 0.0% |
| Q1 2016 | $741,000 | +2.8% | 88,586 | +14.4% | 0.00% | 0.0% |
| Q4 2015 | $721,000 | -16.0% | 77,415 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $858,000 | -11.5% | 76,040 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $969,000 | +69.7% | 76,340 | +24.2% | 0.00% | +100.0% |
| Q1 2015 | $571,000 | -46.0% | 61,442 | -16.8% | 0.00% | -50.0% |
| Q4 2014 | $1,057,000 | +62.6% | 73,842 | +18.0% | 0.00% | 0.0% |
| Q3 2014 | $650,000 | -35.0% | 62,575 | +1.2% | 0.00% | -33.3% |
| Q2 2014 | $1,000,000 | +2.0% | 61,820 | +2.5% | 0.00% | 0.0% |
| Q1 2014 | $980,000 | +31.7% | 60,320 | +0.7% | 0.00% | +50.0% |
| Q4 2013 | $744,000 | +13.6% | 59,920 | +0.3% | 0.00% | 0.0% |
| Q3 2013 | $655,000 | +64.2% | 59,720 | +20.9% | 0.00% | +100.0% |
| Q2 2013 | $399,000 | +107.8% | 49,397 | +0.8% | 0.00% | 0.0% |
| Q1 2013 | $192,000 | – | 48,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |